Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity

被引:184
|
作者
Wu, J. Julie
Roth, Rachel J.
Anderson, Ethan J.
Hong, Eun-Gyoung
Lee, Mi-Kyung
Choi, Cheol Soo
Neufer, P. Darrell
Shulman, Gerald I.
Kim, Jason K.
Bennett, Anton M. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
[5] John B Pierce Fdn Lab, New Haven, CT 06520 USA
关键词
D O I
10.1016/j.cmet.2006.05.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mitogen-activated protein kinases (MAPK) play critical roles in the pathogenesis of diabetes and obesity. The MAPKs are inactivated by MAPK phosphatases (MKPs) either in the cytosol or nucleus. Here we show that mice lacking the nuclear-localized MKP, MKP-1 (mkp-1(-/-)), have enhanced Erk, p38 MAPK and c-Jun NH2-terminal kinase (JNK) activities in insulin-responsive tissues as compared with wild-type mice. Although JNK promotes insulin resistance, mkp-1(-/-) mice exhibited unimpaired insulin-mediated signaling and glucose homeostasis. We reconciled these results by demonstrating that in mkp-1(-/-) mice, JNK activity was increased in the nucleus, but not the cytosol. Significantly, mkp-1(-/-) mice are resistant to diet-induced obesity due to enhanced energy expenditure, but succumb to glucose intolerance on a high fat diet. These results suggest that nuclear regulation of the MAPKs by MKP-1 is essential for the management of metabolic homeostasis in a manner that is spatially uncoupled from the cytosolic actions of the MAPKs.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [1] The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
    Kelly K. Haagenson
    Gen Sheng Wu
    Cancer and Metastasis Reviews, 2010, 29 : 143 - 149
  • [2] The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
    Haagenson, Kelly K.
    Wu, Gen Sheng
    CANCER AND METASTASIS REVIEWS, 2010, 29 (01) : 143 - 149
  • [3] Deficiency of MAP Kinase Phosphatase-1 Induces Pulmonary Hypertension in Mice
    Das, Mita
    Shields, Kristin M.
    Burns, Nana
    Harral, Julie
    Homma, Noriyuki
    Oka, Masahiko
    West, James
    FASEB JOURNAL, 2008, 22
  • [4] MAP kinase phosphatase-1 is induced in abnormal fibers in inclusion body myositis
    Nakano, S
    Shinde, A
    Ito, H
    Ito, H
    Kusaka, H
    NEUROLOGY, 2003, 61 (03) : 322 - 326
  • [5] Regulation of innate immune response by MAP kinase phosphatase-1
    Wang, Xianxi
    Liu, Yusen
    CELLULAR SIGNALLING, 2007, 19 (07) : 1372 - 1382
  • [6] Expression of MAP kinase phosphatase-1 in inclusion body myositis
    Nakano, S
    Shinde, A
    Ito, H
    Ito, H
    Kusaka, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S50 - S50
  • [7] Structure-function studies on MAP kinase phosphatase-1
    Hutter, D
    Liu, Y
    FASEB JOURNAL, 1999, 13 (07): : A1488 - A1488
  • [8] Mice lacking DUSP6/8 have enhanced ERK1/2 activity and resistance to diet-induced obesity
    Liu, Ruijie
    Peters, Monica
    Urban, Nicholas
    Knowlton, Jacob
    Napierala, Tanner
    Gabrysiak, Jessica
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (01) : 17 - 22
  • [9] MAP kinase activation is not required for cyclic AMP-induced expression of MAP kinase phosphatase-1 in PC12 cells
    Burgun, C
    Esteve, L
    Aunis, D
    Zwiller, J
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 344 - 344
  • [10] MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response
    Kirk, Sean G.
    Samavati, Lobelia
    Liu, Yusen
    LIFE SCIENCES, 2020, 241